Welcome to MedicalPress a Premium Medical Theme
Title Image

Publications

    • K. Sonawane, A. G. Nyitray, G. S. Nemutlu, M. D. Swartz, J. Chhatwal, A. A. Deshmukh (2019), “Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women.” JAMA Network Open, 2(12), e1918571-e1918571.
    • J. Chhatwal, Q. Chen, X. Wang, T. Ayer, Y. Zhuo, N. Z. Janjua, F. Kanwal (2019), “Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan.” JAMA Netw Open, 2, 5, Pp. e193613.
    • B. Jahn, J. Todorovic, M. Bundo, G. Sroczynski, A. Conrads-Frank, U. Rochau, G. Endel, I. Wilbacher, N. Malbaski, N. Popper, J. Chhatwal, D. Greenberg, J. Mauskopf, U. Siebert (2019), “Budget Impact Analysis of Cancer Screening: A Methodological Review.” Appl Health Econ Health Policy.
    • Q. Chen, T. Ayer, E. Bethea, F. Kanwal, X. Wang, M. Roberts, Y. Zhuo, S. Fagiuoli, J. Petersen, J. Chhatwal (2019), “Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.” BMJ Open, 9, 6, Pp. e026726.
    • E. D. Bethea, S. Samur, F. Kanwal, T. Ayer, C. Hur, M. S. Roberts, N. Terrault, R. T. Chung, J. Chhatwal (2019), “Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.” Clin Gastroenterol Hepatol, 17, 4, Pp. 739-747.e8.
    • M. J. Klebanoff, K. E. Corey, S. Samur, J. G. Choi, L. M. Kaplan, J. Chhatwal, C. Hur (2019), “Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis.” JAMA Netw Open, 2, 2, Pp. e190047.
    • K. Sonawane, J. Chhatwal, A. A. Deshmukh (2019), “Folic Acid-Containing Dietary Supplement Consumption and Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients: NHANES 1999-2014.” J Gen Intern Med, 34, 1, Pp. 15-16.
    • A. C. Spaulding, J. Chhatwal, M. G. Adee, R. T. Lawrence, C. G. Beckwith, W. von Oehsen (2019), “Funding Hepatitis C Treatment in Correctional Facilities by Using a Nominal Pricing Mechanism.” J Correct Health Care, 25, 1, Pp. 15-24.
    • A. C. Spaulding, C. S. Graham, M. J. Akiyama, J. Chhatwal, A. E. Nijhawan, M. H. Ninburg, J. D. Rich, L. B. Strick, L. E. Taylor, S. B. Trooskin, R. P. Westergaard, W. J. Sabol (2019), “HCV prevalence estimates among incarcerated persons.” Hepatology.
    • J. Chhatwal, Q. Chen, E. D. Bethea, C. Hur, A. C. Spaulding, F. Kanwal (2019), “The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.” Aliment Pharmacol Ther, 50, 1, Pp. 66-74.
    • B. P. Lee, S. Samur, O. O. Dalgic, E. D. Bethea, M. R. Lucey, E. Weinberg, C. Hsu, M. E. Rinella, G. Y. Im, O. K. Fix, G. Therapondos, H. Han, D. W. Victor, M. D. Voigt, S. Eswaran, N. A. Terrault, J. Chhatwal (2019), “Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients with Alcohol-Associated Hepatitis.” Gastroenterology.
    • Q. Chen, M. R. Larochelle, D. T. Weaver, A. P. Lietz, P. P. Mueller, S. Mercaldo, S. E. Wakeman, K. A. Freedberg, T. J. Raphel, A. B. Knudsen, P. V. Pandharipande, J. Chhatwal (2019), “Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States.” JAMA Netw Open, 2, 2, Pp. e187621.
    • T. Ayer, C. Zhang, A. Bonifonte, A. C. Spaulding, J. Chhatwal (2019), “Prioritizing Hepatitis C treatment in US prisons.” Operations Research, 67, 3, Pp. 853-873.
    • J. Chhatwal, N. L. Sussman (2019), “Universal Screening for Hepatitis C: An Important Step in Virus Elimination.” Clin Gastroenterol Hepatol, 17, 5, Pp. 835-837.
    • A. A. Deshmukh, S. M. Shirvani, A. Likhacheva, J. Chhatwal, E. Y. Chiao, K. Sonawane (2018), “The Association Between Dietary Quality and Overall and Cancer-Specific Mortality Among Cancer Survivors, NHANES III.” JNCI Cancer Spectr, 2, 2, Pp. pky022.
    • J. Chhatwal, F. Kanwal (2018), “Cost-effectiveness and Decision Analysis in Clinical Gastroenterology and Hepatology: From Evidence to Informed Decision Making.” Clin Gastroenterol Hepatol, 16, 4, Pp. 459-461.
    • A. Goel, Q. Chen, J. Chhatwal, R. Aggarwal (2018), “Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment.” J Gastroenterol Hepatol, 33, 12, Pp. 2029-2036.
    • J. Chhatwal, Q. Chen, R. Aggarwal (2018), “Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment Using Health Economic Modeling.” Infect Dis Clin North Am, 32, 2, Pp. 461-480.
    • A. C. Spaulding, M. G. Adee, R. T. Lawrence, J. Chhatwal, W. von Oehsen (2018), “Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.” Infect Dis Clin North Am, 32, 2, Pp. 323-345.
    • J. Chhatwal, Q. Chen, E. D. Bethea, M. A. Ladd, P. P. Mueller, Y. Hutin, R. Aggarwal (2018), “Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs.” Lancet Gastroenterol Hepatol, 3, 12, Pp. 819.
    • J. Chhatwal (2018), “Hepatitis C Screening: From Modeling to Public Health Policy.” Clin Infect Dis, 66, 3, Pp. 385-386.
    • Q. Chen, T. Ayer, J. Chhatwal (2018), “Optimal M-Switch surveillance policies for liver cancer in a Hepatitis C–infected population.” Operations Research, 66, 3, Pp. 673-696.
    • E. D. Bethea, Q. Chen, C. Hur, R. T. Chung, J. Chhatwal (2018), “Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.” Hepatology, 67, 3, Pp. 837-846.
    • J. Chhatwal, S. Samur, E. D. Bethea, T. Ayer, F. Kanwal, C. Hur, M. S. Roberts, N. Terrault, R. T. Chung (2018), “Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.” Hepatology, 67, 6, Pp. 2085-2095.
    • R. Suk, P. Mahale, K. Sonawane, A. G. Sikora, J. Chhatwal, K. M. Schmeler, K. Sigel, S. B. Cantor, E. Y. Chiao, A. A. Deshmukh (2018), “Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.” JAMA Netw Open, 1, 5, Pp. e181999.
    • C. Zhang, A. Atasu, T. Ayer, B. Toktay (2018), “Truthful Mechanisms for Medical Surplus Product Allocation.” accepted, M&SOM http://ssrn.com/abstract=3050085
    • T. Ayer, M. Ayvaci, Z. Karaca, J. Vlachy (2018), “The Impact of Health Information Exchanges on Emergency Department Length of Stay.” accepted, Production and Operations Management (POM). http://ssrn.com/abstract=2968618
    • T. Ayer, C. Zhang, A. Bonifonte, A. Spaulding, J. Chhatwal (2018), “Prioritizing Hepatitis C Treatment in U.S. Prisons.” accepted, Operations Research. https://ssrn.com/abstract=2869158
    • T. Ayer, C. Zhang, C. Zeng, C. C. White III, V. R. Joseph (2018), “Analysis and Improvement of Blood Collection Operations.” in press, M&SOM. https://papers.ssrn.com/abstract=3050171
    • M. J. Klebanoff, J. Chhatwal, C. Hur (2017), “Acceptance of Surgical Treatment for Adolescent Obesity-Reply.” JAMA Surg.
    • A. A. Deshmukh, S. B. Cantor, E. Fenwick, E. Y. Chiao, A. G. Nyitray, E. A. Stier, S. E. Goldstone, T. Wilkin, J. Chhatwal (2017), “Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.” Vaccine, 35, 38, Pp. 5102-5109.
    • M. J. Klebanoff, K. E. Corey, J. Chhatwal, L. M. Kaplan, R. T. Chung, C. Hur (2017), “Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis.” Hepatology, 65, 4, Pp. 1156-1164.
    • M. J. Klebanoff, J. Chhatwal, J. D. Nudel, K. E. Corey, L. M. Kaplan, C. Hur (2017), “Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity.” JAMA Surg, 152, 2, Pp. 136-141.
    • R. Aggarwal, Q. Chen, A. Goel, N. Seguy, R. Pendse, T. Ayer, J. Chhatwal (2017), “Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.” PLoS One, 12, 5, Pp. e0176503.
    • S. Samur, B. Kues, T. Ayer, Mark S. Roberts, F. Kanwal, C. Hur, D.M.S. Donnell, R. Chung, J. Chhatwal (2017), “Cost-Effectiveness of Pre versus Post Liver Transplant Hepatitis C Treatment with Direct-Acting Antivirals.” Clin Gastroenterol Hepatol, [in press].
    • J. Chhatwal, T. He, C. Hur, M. A. Lopez-Olivo (2017), “Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving.” Clinical Gastroenterology and Hepatology, 15, 6, Pp. 827-837.e8. Publisher’s Version
    • Q. Chen, N. Jain, T. Ayer, W. G. Wierda, C. R. Flowers, S. M. O’Brien, M. J. Keating, H. M. Kantarjian, J. Chhatwal (2017), “Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States.” J Clin Oncol, 35, 2, Pp. 166-174.
    • M. Capan, A. Khojandi, B. T. Denton, K. D. Williams, T. Ayer, J. Chhatwal, M. Kurt, J. M. Lobo, M. S. Roberts, G. Zaric, S. Zhang, J. S. Schwartz (2017), “From Data to Improved Decisions: Operations Research in Healthcare Delivery.” Med Decis Making, Pp. 272989x17705636.
    • S. Samur, M. Klebanoff, R. Banken, D. S. Pratt, R. Chapman, D. A. Ollendorf, A. M. Loos, K. Corey, C. Hur, J. Chhatwal (2017), “Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis.” Hepatology, 65, 3, Pp. 920-928.
    • A. A. Deshmukh, E. Y. Chiao, S. B. Cantor, E. A. Stier, S. E. Goldstone, A. G. Nyitray, T. Wilkin, X. Wang, J. Chhatwal (2017), “Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.” Cancer, 123, 23, Pp. 4709-4719.
    • K. Sonawane, R. Suk, E. Y. Chiao, J. Chhatwal, P. Qiu, T. Wilkin, A. G. Nyitray, A. G. Sikora, A. A. Deshmukh (2017), “Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014.” Ann Intern Med, 167, 10, Pp. 714-724.
    • Q. Chen, N. Jain, C. R. Flowers, J. Chhatwal (2017), “Reply to C. Nabhan et al.” J Clin Oncol, 35, 16, Pp. 1864-1865.
    • J. Chhatwal, S. Samur, E. Bethea, R. T. Chung (2017), “Response to Optimal Timing for Hepatitis C Antiviral Therapy in the Peri-Transplant Period?” Hepatology.
    • Q. Chen, T. Ayer, J. Chhatwal (2017), “Sensitivity analysis in sequential decision models: A probabilistic approach.” Med Decis Making, 37, 2, Pp. 243-252.
    • Q. Chen, T. Ayer, J. Chhatwal (2017), “Optimal M-switch Surveillance Policies for Liver Cancer in Hepatitis C-Infected Population.” in press, Operations Research, https://ssrn.com/abstract=2966381
    • J. Yan, T. Ayer, P. Keskinocak, A. Caughey (2017), “Age-based Differences in the Predictive Accuracy of a One-Size-Fits-All Risk-Cutoff Value in Prenatal Integrated Screening for Down Syndrome.” in press, Prenatal Diagnosis.
    • Q. Chen, AD Staton, T. Ayer, DA Goldstein, JL Koff, CR Flowers (2017), “Exploring the Potential Cost-Effectiveness of Precision Medicine Treatment Strategies for Diffuse Large B-cell Lymphoma.” in press, Leukemia and Lymphoma
    • D. A. Goldstein, Q. Chen, T. Ayer, K. W. Chan, K Virik, A. Hammerman , B. Brenner , C. R. Flowers , P. S. Hall (2017), “Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis.” The Oncologist, DOI:10.1634/theoncologist.2016-0455 [Epub ahead of print].
    • R. Aggarwal, Q. Chen, A. Goel , N. Seguy , R. Pendse , T. Ayer, J. Chhatwal (2017), “Cost-Effectiveness of Hepatitis C Treatment using Generic Direct-Acting Antivirals Available in India.” PLoS One, https://doi.org/10.1371/journal.pone.0176503 [Epub ahead of print].
    • T. Ayer, C. Zhang, C. Zeng, C. C. White, V. R. Joseph, K. Lee, Z. Ozkaynak, M. Deck (2017), “American Red Cross Uses Analytics-based Methods to Improve Blood Collection Operations.” in press, Interfaces.
    • H. Terawaki, C. Caglayan, Q. Chen, T. Ayer, C. Flowers (2017), “Microsimulation Modeling in Oncology“, “in press, Journal of Clinical Oncology (JCO) Clinical Cancer Informatics.
    • A. R. Ruiz, J. Vlachy, J. W. Lee , E. J. Gilmore , T. Ayer, et al. (2017), “Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients.” JAMA Neurology, 74(2), 181-188.
    • M. Capan, A. Khojandi, B. Denton, KD Williams, T. Ayer, et al. (2017), “From Data to Improved Decisions: Operations Research in Healthcare Delivery.” Medical Decision Making, doi: 10.1177/0272989X17705636 [Epub ahead of print].
    • *S. Samur, B. Kues, T. Ayer , M. S. Roberts, F. Kanwal, C. Hur, D. M. S. Donnell, R. Chung, J. Chhatwal (2017), “Cost-Effectiveness of Pre versus Post Liver Transplant Hepatitis C Treatment with Direct-Acting Antivirals.“, Clinical Gastroenterology and Hepatology, 2018 Jan;16(1):115-122.e10. doi: 10.1016/j.cgh.2017.06.024.
    • J. Chhatwal, S. Jayasuriya, E. H. Elbasha (2016), “Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.” Med Decis Making, 36, 8, Pp. 952-64.
    • C. Besa, S. Lewis, P. V. Pandharipande, J. Chhatwal, A. Kamath, N. Cooper, A. Knight-Greenfield, J. S. Babb, P. Boffetta, N. Padron, C. B. Sirlin, B. Taouli (2016), “Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.” Abdom Radiol (NY).
    • E. H. Elbasha J. Chhatwal (2016), “Myths and Misconceptions of Within-Cycle Correction: A Guide for Modelers and Decision Makers.” Pharmacoeconomics, 34, 1, Pp. 13-22.
    • T. He, K. Li, M. S. Roberts, A. C. Spaulding, T. Ayer, J. J. Grefenstette, J. Chhatwal (2016), “Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.” Ann Intern Med, 164, 2, Pp. 84-92.
    • J. Chhatwal, T. He, M. A. Lopez-Olivo (2016), “Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals.” Pharmacoeconomics, 34, 6, Pp. 551-67
    • M. Cevik, T. Ayer, O. Alagoz (2016), “Analysis of Mammography Screening Policies under Resource Constraints.” in press, Production and Operations Management (POM).
    • J.Chhatwal, X. Wang, T. Ayer, M. Kabiri, R.T. Chung, C. Hur, J. M. Donohue, M. S. Roberts, F. Kanwal (2016), “Hepatitis C Disease Burden in the United States in the Era of Oral Direct-Acting Antivirals.“, Hepatology, 64(5), 1442-1450.
    • J. Chhatwal, S. Samur, B. Kues, T. Ayer, M.S. Roberts, F. Kanwal, C. Hur, D.M.S. Donnell, R. Chung (2016), “Optimal Timing of Hepatitis C Treatment in Patients on The Liver Transplant Waiting List.“, Hepatology, 65(3), 777-788.
    • A. Rodriguez-Ruiz, J. Vlachy, J.W. Lee, E.J. Gilmore, T. Ayer, H Arif Haider, N. Gaspard, J.A. Ehrenberg, B. Tolchin, T. Fantaneanu, A. Fernandez, LJ Hirsch, S. LaRoche (2016), “Periodic and Rhythmic EEG Patterns in the Critically Ill: Features Associated with Seizures.” in press, JAMA Neurology.
    • J. Chhatwal, M. Mathisen, and H. Kantarjian (2015), “Are high drug prices for hematologic malignancies justified? A critical analysis.” Cancer, 121, Pp. 3372-9.
    • E. H. Elbasha and J. Chhatwal (2015), “Characterizing Heterogeneity Bias in Cohort-Based Models.” Pharmacoeconomics, 33, Pp. 857-65.
    • J. Guirguis, J. Chhatwal, J. Dasarathy, J. Rivas, D. McMichael, L. E. Nagy, A. J. McCullough, and S. Dasarathy (2015), “Clinical Impact of Alcohol-Related Cirrhosis in the Next Decade: Estimates Based on Current Epidemiological Trends in the United States.” Alcohol Clin Exp Res, 39, Pp. 2085-94.
    • J. Chhatwal, F. Kanwal, M. S. Roberts, and M. A. Dunn (2015), “Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.” Ann Intern Med, 162, Pp. 397-406.
    • C. W. Seymour, O. Alotaik, D. J. Wallace, A. E. Elhabashy, J. Chhatwal, T. D. Rea, D. C. Angus, G. Nichol, and J. M. Kahn (2015), “County-Level Effects of Prehospital Regionalization of Critically Ill Patients: A Simulation Study.” Crit Care Med, 43, Pp. 1807-15.
    • J. Chhatwal (2015), “Direct-acting antivirals for hepatitis C treatment: effectiveness versus cost–effectiveness.” Future Virology, Pp. 1-4. Publisher’s Version
    • J. Chhatwal and T. He (2015), “Economic evaluations with agent-based modelling: an introduction.” Pharmacoeconomics, 33, 33, Pp. 423-33.
    • A. A. Deshmukh, J. Chhatwal, E. Y. Chiao, A. G. Nyitray, P. Das, and S. B. Cantor (2015), “Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.” Clin Infect Dis, 61, Pp. 1527-35.
    • J. Chhatwal, M. S. Mathisen, and H. M. Kantarjian (2015), “Reply to price and value in cancer care.” Cancer.
    • E. H. Elbasha and J. Chhatwal (2015), “Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods.” Med Decis Making.
    • J. Chhatwal, Q. Chen, and F. Kanwal (2015), “Why We Should Be Willing to Pay for Hepatitis C Treatment.” Clin Gastroenterol Hepatol, 13, Pp. 1711-3.
    • D. A. Goldstein, Q. Chen, T. Ayer, D. Howard, J. Lipscomb, SS Ramalingam , FR Khuri, CR Flowers (2015), “Necitumumab in Metastatic Squamous Lung Cancer: Establishing a Value-Based Cost.“, JAMA Oncology., 1(9), 1293-1300.
    • T. He, K. Li, M.S. Roberts, A. C. Spaulding, T. Ayer, J. J. Grefenstette, J. Chhatwal (2015), “Prevention of Hepatitis C By Screening and Treatment in United States Prisons.“Annals of Internal Medicine, 164(2), 84-92.
    • Q. Chen, T. Ayer, L. Nastoupil, J. L. Koff, L Jean, A. D. Staton, J. Chhatwal, C. R. Flowers (2015), “Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma.” Leukemia and Lymphoma, 57(4), 842-851.
    • G. Rust, S. Zhang,, Z. Yu, L. Caplan, S. Jain, T. Ayer, L. McRoy, R.S. Levine (2015), “Counties Eliminating Racial Disparities in Colorectal Cancer Mortality” Cancer, 122(11), 1735-1748.
    • D. A. Goldstein, B. B. Ahmad, Q. Chen, T. Ayer, D. Howard, J. Lipscomb, B. El-Rayes, C. R. Flowers (2015), “Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer” Journal of Clinical Oncology (JCO), 33(32), 3727-3732.
    • J. Yan, T. Ayer, P. Keskinocak, A. Caughey (2015), “Preference-Sensitive Risk Cutoff Values for Prenatal Integrated Screening Test for Down Syndrome” Prenatal Diagnosis, 35(7), 645-51.
    • A. Bonifonte, T. Ayer, E. Veledar, A. Clarke, P. Wilson (2015), “Antecedent Blood Pressure as a Predictor of Cardiovascular Diseases” Journal of the American Society of Hypertension, 9(9), 690-696.
    • A. D. Staton, J. L. Koff, Q Chen , T. Ayer, C. R. Flowers (2015), “Next-generation prognostic assessment for diffuse large B cell lymphoma” Future Oncology, 20, 1-15.
    • D. A. Goldstein, Q. Chen, T. Ayer, D. Howard, J. Lipscomb, R. D. Harvey, B. El-Rayes, C. R. Flowers (2015), “First and Second line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: A US based cost-effectiveness analysis” Journal of Clinical Oncology (JCO), 33(10), 1112-8
    • T. Ayer, O. Alagoz, N. K. Stout, E. S. Burnside (2015), “Heterogeneity in Women’s Adherence and Its Role on Optimal Breast Cancer Screening Policies.” Management Science, 62 (5), 1339-1362.
    • T. Ayer (2015), “Inverse Optimization for Assessing Emerging Technologies in Breast Cancer Screening.” Annals of Operations Research, 230(1), 57-85.
    • D. J. Wallace, J. M. Kahn, D. C. Angus, C. Martin-Gill, C. W. Callaway, T. D. Rea, J. Chhatwal, K. Kurland, and C. W. Seymour (2014), “Accuracy of prehospital transport time estimation.” Acad Emerg Med, 21, Pp. 9-16.
    • M. Kabiri, A. B. Jazwinski, M. S. Roberts, A. J. Schaefer, and J. Chhatwal (2014), “The changing burden of hepatitis C virus infection in the United States: model-based predictions.” Ann Intern Med, 161, Pp. 170-80.
    • J. Chhatwal, S. Jayasuriya, and E. H. Elbasha (2014), “Changing Cycle Lengths in State-Transition Models: Doing it the Right Way.” ISPOR Connections, 20, Pp. 12-14.
    • M. U. Ayvaci, O. Alagoz, J. Chhatwal, A. Munoz del Rio, E. A. Sickles, H. Nassif, K. Kerlikowske, and E.S. Burnside (2014), “Predicting invasive breast cancer versus DCIS in different age groups.” BMC Cancer, 14, Pp. 584.
    • Q. Chen, T. Ayer, A. C. Rose, LJ Nastoupil, CR Flowers (2014), “Comparing the Cost Effectiveness of Rituximab Maintenance and Radio-immunotherapy Consolidation Therapy Following First-line Chemo-Immunochemotherapies for Follicular Lymphoma” Value in Health, 18(2), 189-97.
    • D. A. Goldstein, Q. Chen, T. Ayer, D. Howard, J. Lipscomb, R. D. Harvey, B. El-Rayes, C. R. Flowers (2014), “Cost Effectiveness Analysis of Pharmacokinetically Guided 5-Fluorouracil therapy in FOLFOX chemotherapy for metastatic colorectal cancer“, Clinical Colorectal Cancer , 13(4), 219-25.
    • T. Ayer, P. Keskinocak, J. Swann (2014), “OR/MS Research in Public Health.” TutORials in Operations Research edited A. Newman and C. Smith, INFORMS
    • S. A. Ferrante, J. Chhatwal, C. A. Brass, A. C. El Khoury, F. Poordad, J. P. Bronowicki, E. H. Elbasha (2013), “Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.” BMC Infect Dis, 13, Pp. 190.
    • E. H. Elbasha, J. Chhatwal, S. A. Ferrante, A. C. El Khoury, P. A. Laires (2013), “Cost-effectiveness analysis of boceprevir for the treatment of chronic hepatitis C virus genotype 1 infection in Portugal.” Appl Health Econ Health Policy, 11, Pp. 65-78.
    • J. Chhatwal, S. A. Ferrante, C. Brass, A. C. El Khoury, M. Burroughs, B. Bacon, R. Esteban-Mur, E. H. Elbasha (2013), “Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.” Value Health, 16, Pp. 973-86.
    • R. Odhiambo, J. Chhatwal, S. A. Ferrante, A. C. El Khoury, E. H. Elbasha  (2013), “Economic evaluation of boceprevir for the treatment of patients with genotype 1 chronic hepatitis C virus infection in Hungary.” Journal of Health Economics and Outcomes Research.
    • O. Alagoz, J. Chhatwal, E. S. Burnside (2013), “Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis.” Decis Anal, 10, Pp. 200-224.
    • K. L. Luangkesorn, F. Ghiasabadi, J. Chhatwal (2013), “A sequential experimental design method to evaluate a combination of school closure and vaccination policies to control an H1N1-like pandemic.” J Public Health Manag Pract, 19 Suppl 2, Pp. S37-41.
    • T. Ayer, Q. Chen, E. S. Burnside (2013), “Artificial Neural Networks in Mammography Interpretation and Diagnostic Decision Making.” Computational and Mathematical Methods in Medicine, doi:10.1155/2013/83250
    • T. Ayer, O. Alagoz, N. K. Stout (2012), “A POMDP Approach to Personalize Mammography Screening Decisions.” Operations Research, 60, p. 1017-1018–21
    • E. S. Burnside, J. Chhatwal, O. Alagoz (2012), “What is the optimal threshold at which to recommend breast biopsy?” PLoS One, 7, Pp. e48820.
    • Q. Chen, T. Ayer, L. J. Nastoupil, R. Sinha, H. Zhang, C. R. Flowers (2012), “Initial Management Strategies for Follicular Lymphoma.” International Journal of Hematologic Oncology, 1, p. 35-45
    • O. Alagoz, T. Ayer, F. S. Erenay (2011), “Operations Research Models in Cancer Screening.“, Encyclopedia of Operations Research and Management Science edited by James J. Cochran, John Wiley & Sons, doi: 10.1002/9780470400531.eorms0597
    • T. Ayer, O. Alagoz, J. Chhatwal, J. W. Shavlik, C. E. Kahn, E. S. Burnside (2010), “Breast Cancer Risk Estimation with Artificial Neural Networks Revisited: Discrimination and Calibration.” Cancer, 116, p. 3310–21
    • T. Ayer, J. Chhatwal, O. Alagoz, C. E. Kahn, R. W. Woods, E. S. Burnside (2010), “Comparison of Logistic Regression and Artificial Neural Network Models with an Example in Breast Cancer Risk Prediction.” RadioGraphics, 30, p.13–22
    • J. Chhatwal, O. Alagoz, E. S. Burnside (2010), “Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors.” Oper Res, 58, Pp. 1577-1591.
    • T. Ayer, M.U.S. Ayvaci, Z.X. Liu, O. Alagoz, E.S. Burnside (2010), “Computer Aided Diagnostic Models in Breast Cancer Screening.” Imaging in Medicine, 2(3), p. 313-23
    • J. Chhatwal, O. Alagoz, M. J. Lindstrom, Jr. Kahn, C. E., K. A. Shaffer, E. S. Burnside (2009), “A logistic regression model based on the national mammography database format to aid breast cancer diagnosis.” AJR Am J Roentgenol, 192, Pp. 1117-27.
    • E. S. Burnside, J. Davis, J. Chhatwal, O. Alagoz, M. J. Lindstrom, B. M. Geller, B. Littenberg, K. A. Shaffer, Jr. Kahn, C. E., C. D. Page (2009), “Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings.” Radiology, 251, Pp. 663-72.